|
|
41
|
|
|
50421
|
|
|
ELOXATIN 5MG/ML INJ SOLN (SFA) OXALIPLATIN (C)
|
|
|
OXALIPLATIN
|
|
|
ELOXATIN
|
|
|
20ML
|
|
|
C
|
|
|
326.2
|
|
|
326.1989
|
|
|
5MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
SFA
|
|
|
SANOFI AVENTIS
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|